Publication: Predicting Survival for Chimeric Antigen Receptor T-Cell Therapy: A Validation of Survival Models Using Follow-Up Data From ZUMA-1

Jess Mann and Ash Bullement have had an original research article published by Value in Health, concerning the estimation of survival outcomes for patients treated with the CAR T-cell therapy axi-cel. The research considers multiple data cuts from the ZUMA-1 trial, finding that cure-based models were best placed to provide plausible extrapolations based on limited follow-up data. You can read the open access article by following this link URL: